Drug Topics September 24, 2024
Johnny Garcia, Senior Director of Policy at the Pharmaceutical Care Management Association, discussed the role his company plays in the ongoing issue of rising drug prices.
Prescription drug prices in the US have soared dramatically in the past few decades. While fingers are being pointed at various entities that make the pharmaceutical supply chain run smoothly, industry experts have spent years to find out who is responsible for unaffordable access to medications.
One of the lesser-known groups that deals with multiple facets of the supply chain—often referred to as pharmaceutical middlemen—pharmacy benefit managers (PBMs) serve as an intermediary between pharmacies, insurance companies and employers, and drug manufacturers and wholesalers.1 Due to vertical integration, formulary design, and other patient-steering tactics, major...